Vanguard Group’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Vanguard Group’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,709,941	Closed	-$474M	–	4206
2014 Q4	$474M	Buy	4,709,941 +127,346	+3%	+$9.9M	0.03%	568
2014 Q3	$304M	Buy	4,582,595 +30,357	+0.7%	+$1.99M	0.02%	734
2014 Q2	$318M	Buy	4,552,238 +32,611	+0.7%	+$2.22M	0.03%	727
2014 Q1	$331M	Buy	4,519,627 +188,433	+4%	+$14.1M	0.03%	675
2013 Q4	$298M	Buy	4,331,194 +555,613	+15%	+$36M	0.03%	687
2013 Q3	$240M	Sell	3,775,581 -516,375	-12%	-$31.2M	0.02%	748
2013 Q2	$207M	Buy	+4,291,956	New	+$211M	0.02%	760

Vanguard Group's CBST Position: Q1 2015 in Review

Vanguard Group sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 4,709,941 shares — an estimated $474M sold.

Vanguard Group first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $474M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

Vanguard Group reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Vanguard Group sold 4,709,941 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $474M.
Vanguard Group first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
Vanguard Group's CUBIST PHARMACEUTICALS INC position peaked at $474M in Q4 2014.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.